Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Neuropharmacology. 2015 Aug 13;99:491–499. doi: 10.1016/j.neuropharm.2015.08.017

Figure 1. Effects of dopamine receptor agonists on Y416 phosphorylation in the rat striatum and mPFC.

Figure 1

(A) Effects of SKF81297 and quinpirole on Y416 phosphorylation and Src and Fyn expression in the striatum. Note that SKF81297 induced a significant increase in Y416 phosphorylation. (B) Effects of SKF81297 and quinpirole on Y416 phosphorylation and Src and Fyn expression in the mPFC. Representative immunoblots are shown left to the quantified data. Rats were given a single dose of SKF81297 (3 mg/kg, i.p.) or quinpirole (3 mg/kg, i.p.) and sacrificed 20 min after drug injection for immunoblot analysis. Data are presented as means ± SEM (n = 4 per group). *P < .05 versus saline (one-way ANOVA).